Hemogenyx Pharmaceuticals Plc (LON:HEMO)
London · Delayed Price · Currency is GBP · Price in GBX 880.00
+15.00 (1.73%)
Apr 15, 2026, 4:35 PM GMT
Hemogenyx Pharmaceuticals Market Cap
Hemogenyx Pharmaceuticals has a market cap or net worth of 56.54 million as of April 15, 2026. Its market cap has increased by 613.85% in one year.
Market Cap
56.54M
Enterprise Value
58.47M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
880.00
Market Cap Chart
Since October 6, 2017, Hemogenyx Pharmaceuticals's market cap has increased from 10.68M to 56.54M, an increase of 429.37%. That is a compound annual growth rate of 21.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 55.58M | 60.84% |
| Dec 31, 2025 | 34.56M | 143.47% |
| Dec 31, 2024 | 14.19M | -47.51% |
| Dec 29, 2023 | 27.04M | 108.28% |
| Dec 30, 2022 | 12.98M | -29.33% |
| Dec 31, 2021 | 18.37M | -56.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 6, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scancell Holdings | 129.72M |
| Bioventix | 95.35M |
| 4basebio | 78.16M |
| hVIVO | 59.19M |
| Ondine Biomedical | 58.45M |
| Faron Pharmaceuticals Oy | 51.41M |
| Poolbeg Pharma | 31.73M |
| ImmuPharma | 30.67M |